These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 19538102

  • 21. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA.
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [Abstract] [Full Text] [Related]

  • 22. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 23. A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone.
    Cobitz A, Zambanini A, Sowell M, Heise M, Louridas B, McMorn S, Semigran M, Koch G.
    Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):769-81. PubMed ID: 18613278
    [Abstract] [Full Text] [Related]

  • 24. Combination of drugs in the management of diabetes mellitus.
    Das S.
    J Indian Med Assoc; 2002 Jul; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [Abstract] [Full Text] [Related]

  • 25. Which oral drug is right for your type 2 diabetes? New thinking on oral drug combinations that can provide better glycemic control.
    Health News; 2005 Feb; 11(2):10-1. PubMed ID: 15732153
    [No Abstract] [Full Text] [Related]

  • 26. Beyond insulin replacement: addressing the additional needs of the diabetes patient.
    Dailey G.
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():83-97. PubMed ID: 18577160
    [Abstract] [Full Text] [Related]

  • 27. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE, Hoehns JD.
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract] [Full Text] [Related]

  • 28. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY, Macaluso M, McHale RJ, Dahmen MM, Girrens K, Ali F.
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Drugs for diabetes.
    Abramowicz M, Zuccotti G, Medical Letter.
    Treat Guidel Med Lett; 2005 Aug; 3(36):57-62. PubMed ID: 16012392
    [No Abstract] [Full Text] [Related]

  • 35. Cardiovascular risk of rosiglitazone: another perspective.
    Waksman JC.
    J Pharm Pharmacol; 2008 Dec; 60(12):1573-82. PubMed ID: 19000361
    [Abstract] [Full Text] [Related]

  • 36. The association between diabetes medication and weight change in a non-surgical weight management intervention: an intervention cohort study.
    Aldekhail NM, Morrison DS, Khojah H, Sloan B, McLoone P, MacNaughton S, Shearer R, Logue J.
    Diabet Med; 2020 Feb; 37(2):248-255. PubMed ID: 31365143
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.